Inhibition of LncRNAH19 has the effect of anti‐tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non‐small‐cell lung cancer in vivo
Authors:
Open Access
- 13 April 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (10) , 5811-5816
Abstract
Lung cancer is one of the most common malignant diseases, which ranked first in both men and women malignancies worldwide. The survival rate of non‐small‐cell lung cancer (NSCLC) has been limited with distant metastasis and shortage of effective chemotherapeutics in recent years. Thus, novel therapeutic strategies for NSCLC are urgently explored. Here, we showed that inhibition of H19 effectively inhibited the progression of NSCLC. Moreover, down‐regulation of H19 treatment significantly enhanced the levels of PTEN and PDCD4, while suppressed the expressions of NFIB in NSCLC. Furthermore, down‐regulation of H19 combined with Gefitinib treatment significantly increased the levels of PTEN and PDCD4, while decreased the expression levels of NFIB. Moreover, the results showed that Gefitinib treatment significantly reduced the shH19‐mediated miR‐21 expression levels. Our results showed that down‐regulation of H19 combined with Gefitinib administration significantly improved the effect of shH19 treatment alone on the progression of NSCLC, which was involved in the activation of PTEN signalling pathway in NSCLC in vivo. Therefore, these findings might indicate a novel molecular mechanism, which could provide a new potential combination of therapeutic method in NSCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81902310)
This publication has 31 references indexed in Scilit:
- Long Non-Coding RNAs in Cardiac RemodelingCellular Physiology and Biochemistry, 2017
- PEG3 binds to H19-ICR as a transcriptional repressorEpigenetics, 2016
- Biological and Clinical Relevance of H19 in Colorectal Cancer PatientsEBioMedicine, 2016
- A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain InflammationCell, 2016
- H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancerNeoplasma, 2016
- Lung Cancer Statistics2015
- c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.2015
- The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on biological roles and therapeutic potential in Lung CancerJournal of Translational Medicine, 2015
- Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescenceNature, 2013
- Smoking status and survival in the national comprehensive cancer network non–small cell lung cancer cohortCancer, 2012